Advertisement

Advertisement

JP:4883 Stock Latest News

Modalis Therapeutics Issues 18th Series Stock Options to Align Incentives and Retain Talent

Company AnnouncementsModalis Therapeutics Issues 18th Series Stock Options to Align Incentives and Retain Talent

Modalis Outlines FY2025 Growth Plans in Confidential TSE-Mandated Update

PremiumCompany Announcements

Modalis Outlines FY2025 Growth Plans in Confidential TSE-Mandated Update

4d ago

Modalis Therapeutics Seeks Approval for Virtual-Ready Shareholder Meetings

PremiumCompany Announcements

Modalis Therapeutics Seeks Approval for Virtual-Ready Shareholder Meetings

1M ago

Modalis to Wipe Out Retained Earnings Deficit via Capital Reduction

PremiumCompany Announcements

Modalis to Wipe Out Retained Earnings Deficit via Capital Reduction

1M ago

Modalis Slows IND Timeline for Lead CRISPR Program as It Strengthens Clinical Readiness

PremiumCompany Announcements

Modalis Slows IND Timeline for Lead CRISPR Program as It Strengthens Clinical Readiness

2M ago

Modalis Loss Widens on Higher R&D Spend Amid Zero Revenue in FY2025

PremiumCompany AnnouncementsModalis Loss Widens on Higher R&D Spend Amid Zero Revenue in FY2025

2M ago

Modalis Books Foreign Exchange Gain for FY2025 on Currency Revaluation

Company Announcements

Modalis Books Foreign Exchange Gain for FY2025 on Currency Revaluation

2M ago

Modalis Issues FY2025 Report With Strict Confidentiality and Risk Disclaimers

Company Announcements

Modalis Issues FY2025 Report With Strict Confidentiality and Risk Disclaimers

2M ago

Modalis posts wider losses in 2025, with no revenue and no 2026 guidance

PremiumCompany Announcements

Modalis posts wider losses in 2025, with no revenue and no 2026 guidance

2M ago

Modalis Therapeutics Issues New Shares for Employee Incentive Plan

PremiumCompany Announcements

Modalis Therapeutics Issues New Shares for Employee Incentive Plan

5M ago

Modalis Therapeutics Reports Foreign Exchange Loss

PremiumCompany Announcements

Modalis Therapeutics Reports Foreign Exchange Loss

5M ago

Modalis Therapeutics Reports Increased Losses and Decline in Financial Position

PremiumCompany Announcements

Modalis Therapeutics Reports Increased Losses and Decline in Financial Position

5M ago

Modalis Therapeutics Announces Key Executive Appointments

PremiumCompany AnnouncementsModalis Therapeutics Announces Key Executive Appointments

6M ago

Modalis Therapeutics Reports Foreign Exchange Loss Impacting Earnings

Company Announcements

Modalis Therapeutics Reports Foreign Exchange Loss Impacting Earnings

8M ago

Modalis Therapeutics Reports Financial Results for H1 2025

Company Announcements

Modalis Therapeutics Reports Financial Results for H1 2025

8M ago

Modalis Therapeutics Issues New Shares for Employee Compensation

PremiumCompany Announcements

Modalis Therapeutics Issues New Shares for Employee Compensation

9M ago

Modalis Therapeutics Partners with Broad Institute for Gene Therapy Advancement

PremiumCompany Announcements

Modalis Therapeutics Partners with Broad Institute for Gene Therapy Advancement

9M ago

Modalis Completes New Share Issuance for Employee Remuneration

PremiumCompany Announcements

Modalis Completes New Share Issuance for Employee Remuneration

9M ago

Modalis Therapeutics Issues New Shares for Employee Compensation

PremiumCompany Announcements

Modalis Therapeutics Issues New Shares for Employee Compensation

10M ago

Modalis Completes New Share Issuance for Employee Remuneration

PremiumCompany AnnouncementsModalis Completes New Share Issuance for Employee Remuneration

10M ago

Modalis Therapeutics Issues New Shares for Stock-Based Remuneration

Company Announcements

Modalis Therapeutics Issues New Shares for Stock-Based Remuneration

11M ago

Modalis Therapeutics Named Finalist in XPRIZE Healthspan Competition

Company Announcements

Modalis Therapeutics Named Finalist in XPRIZE Healthspan Competition

11M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >